[Research advances in occurrence risk assessment and early-stage diagnosis of hepatocellular carcinoma].

Abstract

Evaluating and identifying the occurrence risk of hepatocellular carcinoma (HCC) can make the gateway for prevention and diagnosis advance as well as assist in the early detection and intervention of future HCC occurrences within the population. Early-stage diagnosis and treatment are crucial for improving survival rates in patients with HCC. This article reviews the recent years' research progress in terms of combining three aspects-molecular markers, scoring models, and early-stage diagnostics-to predict the evaluation of HCC occurrence risk, with the hope of providing guiding significance for clinical practice.